berberine and phytosterols

berberine has been researched along with phytosterols in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's2 (40.00)24.3611
2020's2 (40.00)2.80

Authors

AuthorsStudies
Chen, Y; Jia, X; Sun, C; Wang, Y; Zhang, J; Zidichouski, J1
Cicero, AF; Colletti, A1
Bianconi, V; Cosentino, T; Mannarino, MR; Pirro, M; Sahebkar, A1
Colletti, A; Cravotto, G; Fratter, A; Pellizzato, M1
Laffin, LJ; Mirzai, S1

Reviews

4 review(s) available for berberine and phytosterols

ArticleYear
Combinations of phytomedicines with different lipid lowering activity for dyslipidemia management: The available clinical data.
    Phytomedicine : international journal of phytotherapy and phytopharmacology, 2016, Oct-15, Volume: 23, Issue:11

    Topics: Berberine; Biological Products; Cholesterol; Clinical Trials as Topic; Dietary Supplements; Drug Therapy, Combination; Dyslipidemias; Fatty Alcohols; Humans; Lipids; Phytosterols; Phytotherapy; Plant Proteins; Silymarin

2016
Cholesterol-Lowering Nutraceuticals Affecting Vascular Function and Cardiovascular Disease Risk.
    Current cardiology reports, 2018, 05-25, Volume: 20, Issue:7

    Topics: Anticholesteremic Agents; Berberine; Biological Products; Cardiovascular Diseases; Cholesterol; Curcumin; Dietary Fiber; Dietary Supplements; Glycine max; Humans; Phytosterols; Polyphenols

2018
Nutraceutical Approaches to Dyslipidaemia: The Main Formulative Issues Preventing Efficacy.
    Nutrients, 2022, Nov-11, Volume: 14, Issue:22

    Topics: Berberine; Dietary Supplements; Dyslipidemias; Humans; Lipids; Phytosterols

2022
Supplements for Lipid Lowering: What Does the Evidence Show?
    Current cardiology reports, 2023, Volume: 25, Issue:8

    Topics: Animals; Berberine; Dietary Supplements; Humans; Lovastatin; Phytosterols

2023

Other Studies

1 other study(ies) available for berberine and phytosterols

ArticleYear
Co-administration of berberine and plant stanols synergistically reduces plasma cholesterol in rats.
    Atherosclerosis, 2008, Volume: 201, Issue:1

    Topics: Administration, Oral; Animals; Anticholesteremic Agents; Berberine; Cholesterol; Diet, Atherogenic; Drug Therapy, Combination; Lipoproteins; Male; Phytosterols; Rats; Rats, Sprague-Dawley; Sitosterols; Triglycerides

2008